Clinical Trial Participation

INSYS Therapeutics is recognized for its advances surrounding a progressive line of innovative drugs and novel drug delivery systems that improve the quality of patients' lives.

Through our clinical team, we aim to develop cutting-edge therapies that set new standards in supportive care and cancer treatment. Our team is dedicated to exploring interventions, examining methods and measuring ways to improve the comfort and quality of patients' lives. Research participation is vital to our success.

Compound Area of Research  
Fentanyl Sublingual Spray Various Pain Types  
Dronabinol Oral Solution Nausea / Vomiting Associated with Cancer Chemotherapy and Anorexia / Weight Loss in Patients with AIDS  
Cannabidiol Dravet Syndrome and Lennox – Gastaut Syndrome  
Buprenorphine Sublingual Spray Moderate to Severe Pain  
Buprenorphine Naloxone Sublingual Spray Opioid Dependence  
Naloxone Sublingual Spray Reversal of Opioid Depression  
Ondansetron Sublingual Spray Prevention of Nausea and Vomiting  
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Cervical and Cholangiocarcinoma  

COMPOUND

For Physicians and/or Sites Interested in Clinical Trials

INSYS Therapeutics regularly reviews clinical trial research site, investigator and program information from interested parties. To be reviewed, site and investigator information should be submitted to INSYS via email at clinicaltrials@insysrx.com.

 

Participate